SSA
HBIO icon

Schonfeld Strategic Advisors’s Harvard Bioscience HBIO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-35,000
Closed -$1.51M – 1092
2019
Q1 		$1.51M Buy
35,000
+12,500
+56% +$453K 0.05% 403
2018
Q4 		$716K Sell
22,500
-12,560
-36% -$495K 0.03% 555
2018
Q3 		$1.84M Buy
35,060
+17,560
+100% +$986K 0.08% 303
2018
Q2 		$936K Buy
17,500
+5,000
+40% +$256K 0.05% 404
2018
Q1 		$625K Buy
+12,500
New +$560K 0.05% 427

Other funds holding HBIO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Schonfeld Strategic Advisors's HBIO Position: Q2 2019 in Review

Schonfeld Strategic Advisors sold out of Harvard Bioscience (HBIO) in Q2 2019, closing a stake of 35,000 shares — an estimated $1.51M sold.

Schonfeld Strategic Advisors first reported a position in HBIO in Q1 2018 and held it in 5 quarters. The position peaked at $1.84M in Q3 2018. 78 funds tracked by Wall St. Rank hold HBIO as of Q2 2019.

  • Schonfeld Strategic Advisors reported no remaining Harvard Bioscience position as of Q2 2019 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 35,000 Harvard Bioscience shares in Q2 2019, an estimated $1.51M.
  • Schonfeld Strategic Advisors first reported a position in Harvard Bioscience in Q1 2018 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's Harvard Bioscience position peaked at $1.84M in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.